Our current research and clinical activities specialize in plasma cell disorders with a focus on understanding oncogenomic changes in myeloma and developing translational research programs in myeloma. We are a part of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute.